Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
Rui ZhaoShuai RenChangyin LiKai GuoZipeng LuLei TianJian HeKai ZhangYing-Ying CaoShijia LiuDonghui LiZhong-Qiu WangPublished in: Cancer medicine (2022)
The novel metabolite biomarker panel identified in this study exhibited promising performance in distinguishing PDAC from BP or Ctr, especially in combination with CA19-9.
Keyphrases